Monday, August 31, 2020

Which Cancer Patients are Most Susceptible to Severe Effects from COVID-19

›
It’s well known that COVID-19 patients with comorbidities have poorer outcomes than otherwise healthy patients. When it comes to cancer, ho...

Quiet period ends on Acutus Medical; stock rallies on analysts ratings

›
Analyst coverage opens up on Acutus Medical ( AFIB +14.1%). William Blair launches the online marketplace stock with a Outperform ...

FDA Ad Com thumbs down on mortality benefit claim for Glaxo’s Trelegy Ellipta

›
The FDA’s Pulmonary-Allergy Drugs Advisory Committee voted 14-1 that the results from the IMPACT study evaluating GlaxoSmithKline’s ( GSK ...

FDA OKs Medtronic automated insulin system for young kids

›
The FDA approves Medtronic’s (NYSE: MDT ) MiniMed 770G System, a hybrid closed-loop diabetes management device, for children ages 2 – 6 wit...

AstraZeneca backs safety guides in development of COVID-19 vaccine

›
In a statement , AstraZeneca (NYSE: AZN ) reemphasizes its commitment to the highest safety standards and broad equitable global access to ...

Bayer to buy vitamin firm Care/Of in deal valued at $225M

›
August 31, 2020 Bayer ( OTCPK:BAYRY ) has agreed to buy 70% of online vitamin and health supplement company Care/of ...

Axsome has development plans on AXS-05 for Alzheimer’s agitation

›
Axsome Therapeutics ( AXSM -2.7%) confirms pivotal development status and plan for AXS-05 in the treatment of Alzheimer’s disease (AD) ag...